首页> 外文OA文献 >PP-126 Analysis of the virological features and impact on the efficacy treated with peginterferon alfa-2a and ribavirin in patients coinfected with HBV and HCV

【2h】

PP-126 Analysis of the virological features and impact on the efficacy treated with peginterferon alfa-2a and ribavirin in patients coinfected with HBV and HCV

机译：PP-126乙肝病毒和丙肝病毒合并感染患者接受聚乙二醇干扰素α-2a和利巴韦林治疗的病毒学特征及其对疗效的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yu Jian-wu; Sun Li-jie; Zhao Yong-hua; Li Shu-chen;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. PP-126 Analysis of the virological features and impact on the efficacy treated with peginterferon alfa-2a and ribavirin in patients coinfected with HBV and HCV [J] . Jian-wu Yu, Li-jie Sun, Yong-hua Zhao, International journal of infectious diseases : . 2009,第Supplementa1期

机译：PP-126对乙肝病毒和丙肝病毒合并感染的患者使用聚乙二醇干扰素α-2a和利巴韦林治疗的病毒学特征及其对疗效的影响分析
2. Degree of viral decline early in treatment predicts sustained virological response in HCV-HIV coinfected patients treated with peginterferon alfa-2a and ribavirin. [J] . Rodriguez Torres M, Torriani F, Rockstroh J, HIV clinical trials . 2010,第1期

机译：治疗初期病毒下降的程度预示了接受聚乙二醇干扰素α-2a和利巴韦林治疗的HCV-HIV合并感染患者的持续病毒学应答。
3. Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients. [J] . Breilh D, Djabarouti S, Trimoulet JAIDS: Journal of acquired immune deficiency syndromes . 2009,第3期

机译：利巴韦林的血浆浓度可预测先前治疗过的HCV-HIV合并感染患者对聚乙二醇干扰素Alfa 2a加利巴韦林的持续病毒学应答。
4. Patients with HCV/HIV Co-infection Achieving a Sustained Virological Response Following HCV Treatment with Peginterferon alfa-2a (PEGASYS) plus Ribavirin (COPEGUS) have Improved Health Related Quality of Life [C] . D.T. Dieterich, M. Rodriguez Torres, J.K. Rockstroh International AIDS Conference . 2004

机译：HCV / HIV的患者在用Peginterferon Alfa-2a（Pegasys）加上利巴韦林（Copegegs）后HCV治疗后实现持续的病毒学反应，具有改善的健康相关的生活质量
5. A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin [O] . Tarik Asselah, Alex J. Thompson, Robert Flisiak, -1

机译：一种选择模型的HCV基因型3型慢性感染患者对聚乙二醇干扰素Alfa-2a /利巴韦林具有持续病毒学应答的高可能性的预测模型
6. A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin. [O] . Tarik Asselah, Alex J Thompson, Robert Flisiak, 2016

机译：选择HCV基因型3慢性感染患者的预测模型，其对聚乙二醇干扰素α-2a /利巴韦林具有高度持续病毒学应答的可能性。

PP-126 Analysis of the virological features and impact on the efficacy treated with peginterferon alfa-2a and ribavirin in patients coinfected with HBV and HCV

著录项

引文网络

相似文献

相关主题

期刊订阅